Approximately, 83–97% XLP patients were attributed to pathogenic variants of SH2D1A gene and subclassified as XLP1; while 12% attributed to XIAP gene and subclassified as XLP2 (OMIM 300635)[28–30]. This evidence concerns the gene SH2D1A and X-linked lymphoproliferative disease.